Adverse outcomes (AOs) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) treated with intensified androgen deprivation therapy (ADT+). This is an ASCO Meeting Abstract ...
Advancements in integrated circuitry hold promise for the future of wearables, the Internet of Things, and, in turn, hospitals and the way they interact with patients. Details on the world’s fastest ...
Longitudinal race/ethnicity (R/E) specific trends in patient-reported outcomes (PRO) in elderly women with breast cancer (BC) in the SEER-MHOS database. This is an ASCO Meeting Abstract from the 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback